Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'.
Eur J Heart Fail. 2021;23(6):1057-1058.
MeSH terms: Benzoxazoles; Cardiomyopathies; Heart Failure; Humans; Prealbumin
DOI: 10.1002/ejhf.2074